Big-Data-Driven M&A in Pharma: The Competitive Edge of Site-level Intelligence

Private equity investments are transforming the pharmaceutical manufacturing sector, unlocking new opportunities amid shifting global market dynamics. With over 1,400 manufacturing sites across Europe, strategic acquisitions require data-driven insights to navigate compliance risks, ownership complexities, and supply chain dependencies. Discover how advanced analytics platforms empower investors to make informed M&A decisions and gain a competitive edge in this evolving landscape.